public offering

Biotech

Day One spends day 2 hitting up public markets for $150M

Just two days after Day One doubled shares on a data drop for its pediatric brain cancer drug, the biotech is circling up to raise some cash.
Gabrielle Masson Jun 15, 2022 11:16am

Zai Lab aims for $750M to bankroll licensing deals

Apr 20, 2021 3:30pm

Annexon, AlloVir gun for $100M IPOs

Jul 7, 2020 8:05am

Twist Bioscience nets $140M plus a slew of new DNA partnerships

Feb 26, 2020 12:03pm

Axovant buys more gene therapies, looking toward a busy 2019

Dec 14, 2018 7:42am

AI data miner Sensyne Health looks to go public with $77M listing

Aug 7, 2018 8:46pm